Interventional Cardiology Devices Market to Reach US$11.2 Billion by 2022 due to Increasing Incidence of Coronary Artery Diseases: Transparency Market Research

Albany, NY, Nov. 30, 2015 (GLOBE NEWSWIRE) — A new report has been published by Transparency Market Research, titled “Interventional Cardiology Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022“. TMR, a market intelligence company based in the U.S., states that the global interventional cardiology devices market was estimated at US$8.7 billion in 2013, is expanding at a CAGR of 2.9% from 2014 to 2022, and is predicted to reach US$11.2 billion in 2022.As per the TMR report, it was about 50 years ago that coronary artery bypass surgery (CABG) was developed for treating multi-vessel coronary artery disease (CAD) and complex ischemia. Interventional cardiology is defined as a minimally invasive catheter-based technology and minimally invasive surgeries have several benefits such as reduced cost, shorter hospital stay, minimal incision, shorter recovery time, and less post-surgical complications. These benefits are helping growth of the interventional cardiology devices market.

Browse the full Interventional Cardiology Devices Market: (By Types: Stents, Catheters, PTCA Balloons, PTCA Guidewires, Imaging Systems and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022 report at http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

According to this TMR report, on the basis of device type, the global market for interventional cardiology devices market is segmented into: catheters, stents, percutaneous transluminal coronary angioplasty (PTCA) guide wires, percutaneous transluminal coronary angioplasty (PTCA) balloons, and others.Amongst these, the biggest share was held by the stents segment. Stents are further bifurcated into drug eluting stents, bare metal stents, and bioabsorbable vascular stents. Amongst these, in 2014, the drug eluting stents held the biggest market share in the global market for interventional cardiology devices and is set to govern the market through the forecasting horizon.The TMR report states that the increasing incidence of coronary artery diseases and increasing geriatric population are amongst the major reasons stimulating the development of the global interventional cardiology market. Rising incidence of factors such as obesity, smoking, and dietary irregularities are responsible for the rising prevalence of cardiac artery diseases.

Get Sample Report Copy of Interventional Cardiology Devices Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=853

Nonetheless, CABG procedures are experiencing a decline because of the evolution of interventional techniques, as per the studies directed by the NCBI. In Europe, CAD is responsible for about 1.9 million deaths every year, of which more than 400,000 are premature deaths. Thus, the disease is a key cause of premature deaths in Europe. Therefore, the increased occurrence of coronary artery diseases will rise demand for percutaneous coronary interventions, which would boost the development of the market for interventional cardiology devices.As per this TMR research report, this market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and North Africa, and Rest of the World (RoW). North America led the market for global interventional cardiology devices, trailed by Europe, due to the consistent implementation of drug eluting stents, which are premium priced.

Browse Press Release of Interventional Cardiology Devices Market: http://www.transparencymarketresearch.com/pressrelease/interventional-cardiology-devices.htm

Asia Pacific stood as the third biggest market for interventional cardiology devices. This region is predicted to record the highest CAGR through the forecasting horizon. Developing healthcare infrastructure and rising occurrence of coronary artery disease will stimulate the development of this market in the region.Key players in the interventional cardiology devices market include Cordis Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, St. Jude Medical, Inc., Medtronic, plc, Terumo Medical Corporation, and Smiths Medical.

Other Reports Published by Transparency Market Research:

Key Segments of the Interventional Cardiology Devices Market

Global Interventional Cardiology Devices Market, by Device Type

  • Stents

o   Bare Metal Stents

o   Drug-Eluting Stents

o   Bio-absorbable Stents

  • Catheters

o   Angiography Catheters

o   Guiding Catheters

o   Pulmonary Artery Catheters

o   Intravascular ultrasound (IVUS) Catheters

  • PTCA Balloons

o   Normal Balloons

o   Cutting Balloons

o   Scoring Balloons

o   Drug-eluting Balloons

  • Imaging Systems

o   IVUS (intravascular ultrasound)

o   FFR (Fractional Flow Reserve)

o   OCT (Optical Coherence Tomography)

  • Percutaneous Transluminal Coronary Angioplasty Guidewires
  • Others

Global Interventional Cardiology Devices Market, by Geography

  • North America

o   U.S.

o   Canada

  • Europe

o   U.K.

o   Germany

o   Rest of Europe

  • Asia Pacific

o   China

o   India

o   Rest of Asia Pacific

  • Latin America (LATAM)

o   Brazil

o   Mexico

o   Rest of LATAM

  • Middle East North Africa (MENA)

o   Saudi Arabia

o   United Arab Emirates

o   Rest of MENA

  • Rest of the World (RoW)

About Us:

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

CONTACT: Mr. Nachiket Ghumare
         
         90 State Street, Suite 700
         Albany, NY 12207
         United States.
         Tel: +1-518-618-1030
         USA - Canada Toll Free: 866-552-3453
         Email: sales@transparencymarketresearch.com
         Website: http://www.transparencymarketresearch.com
         Blog: http://www.tmrblog.com/

Ads